Hypertrophic Cardiomyopathy (HCM) Latest Advances

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 03, 2025

New Cardiovascular Model Integrating Coronary Circulation in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 03, 2025

Filters

Gene Editing in Cardiac Disease: A Review of the Literature.

Gene Editing in Cardiac Disease: A Review of the Literature.

Hypertrophic Cardiomyopathy is a Disease of Altered Metabolism: Interdependence of Hypercontractility, Oxidative Stress, and Creatine Kinase Dysfunction.

Hypertrophic Cardiomyopathy is a Disease of Altered Metabolism: Interdependence of Hypercontractility, Oxidative Stress, and Creatine Kinase Dysfunction.

When Validation Reveals the Limits - The Next Step in Sudden Death Prevention for Hypertrophic Cardiomyopathy.

When Validation Reveals the Limits - The Next Step in Sudden Death Prevention for Hypertrophic Cardiomyopathy.

Clinical characteristics of 41 children with hypertrophic cardiomyopathy: A single-center retrospective study.

Clinical characteristics of 41 children with hypertrophic cardiomyopathy: A single-center retrospective study.

Surgical Myectomy with Anterior Mitral Leaflet Extension Versus Isolated Myectomy.

Surgical Myectomy with Anterior Mitral Leaflet Extension Versus Isolated Myectomy.

Validation of the 2018 Japanese Circulation Society (JCS)/Japanese Heart Failure Society (JHFS) Guidelines for Preventing Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy.

Validation of the 2018 Japanese Circulation Society (JCS)/Japanese Heart Failure Society (JHFS) Guidelines for Preventing Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy.

Artificial intelligence-enhanced electrocardiography and sudden death risk factors in cardiac arrest survivors diagnosed with hypertrophic cardiomyopathy.

Artificial intelligence-enhanced electrocardiography and sudden death risk factors in cardiac arrest survivors diagnosed with hypertrophic cardiomyopathy.

Prevalence and characteristics of transient myocardial thickening in cats with hypertrophic cardiomyopathy phenotypes.

Prevalence and characteristics of transient myocardial thickening in cats with hypertrophic cardiomyopathy phenotypes.

Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM.

Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM.

A challenging case of transvenous pacemaker implant in a patient with anomalous pulmonary venous drainage.

A challenging case of transvenous pacemaker implant in a patient with anomalous pulmonary venous drainage.

Extraction of Risk Markers from ECG in Patients with Hypertrophic Cardiomyopathy.

Extraction of Risk Markers from ECG in Patients with Hypertrophic Cardiomyopathy.

New Cardiovascular Model Integrating Coronary Circulation in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy.

New Cardiovascular Model Integrating Coronary Circulation in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy.

When Validation Reveals the Limits　- The Next Step in Sudden Death Prevention for Hypertrophic Cardiomyopathy.

When Validation Reveals the Limits　- The Next Step in Sudden Death Prevention for Hypertrophic Cardiomyopathy.